These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
482 related items for PubMed ID: 8839545
21. Lobular carcinoma in situ of the breast. Goldschmidt RA, Victor TA. Semin Surg Oncol; 1996; 12(5):314-20. PubMed ID: 8873318 [Abstract] [Full Text] [Related]
22. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R, Wazer DE. Cancer; 2007 Dec 15; 110(12):2648-53. PubMed ID: 17960606 [Abstract] [Full Text] [Related]
23. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Fisher ER, Anderson S, Redmond C, Fisher B. Semin Surg Oncol; 1992 Dec 15; 8(3):161-6. PubMed ID: 1496227 [Abstract] [Full Text] [Related]
24. Lobular carcinoma in situ (LCIS): pathology and treatment. Gump FE. J Cell Biochem Suppl; 1993 Dec 15; 17G():53-8. PubMed ID: 8007710 [Abstract] [Full Text] [Related]
25. [Carcinoma in situ of the breast]. Laenkholm AV, Hoffmann J, Rank FE. Ugeskr Laeger; 2007 Sep 10; 169(37):3087-90. PubMed ID: 17877955 [Abstract] [Full Text] [Related]
26. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R. Am J Surg; 2006 Oct 10; 192(4):427-33. PubMed ID: 16978943 [Abstract] [Full Text] [Related]
27. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Hwang N, Schiller DE, Crystal P, Maki E, McCready DR. Ann Surg Oncol; 2009 Nov 10; 16(11):3000-9. PubMed ID: 19603233 [Abstract] [Full Text] [Related]
28. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Petit JY, Veronesi U, Orecchia R, Luini A, Rey P, Intra M, Didier F, Martella S, Rietjens M, Garusi C, DeLorenzi F, Gatti G, Leon ME, Casadio C. Breast Cancer Res Treat; 2006 Mar 10; 96(1):47-51. PubMed ID: 16261402 [Abstract] [Full Text] [Related]
29. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB. Cancer; 2003 Jan 01; 97(1):1-11. PubMed ID: 12491499 [Abstract] [Full Text] [Related]
30. [In situ carcinomas of the breast: clinical features and therapeutic strategies]. Attene F, Scognamillo F, Trignano E, Meloni GB, Rubino C, Trignano M. Ann Ital Chir; 2006 Jan 01; 77(1):3-10; discussion 10-2. PubMed ID: 16910353 [Abstract] [Full Text] [Related]
31. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer]. Aulmann S, Penzel R, Schirmacher P, Sinn HP. Verh Dtsch Ges Pathol; 2007 Jan 01; 91():208-13. PubMed ID: 18314616 [Abstract] [Full Text] [Related]
32. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F. Cancer; 2005 Jul 01; 104(1):20-9. PubMed ID: 15912514 [Abstract] [Full Text] [Related]
33. [The treatment of carcinoma in situ of the breast]. Raudrant D, Golfier F, Unger P. Rev Fr Gynecol Obstet; 1990 Feb 01; 85(2):91-6. PubMed ID: 2157271 [Abstract] [Full Text] [Related]
34. Lobular neoplasia on core needle biopsy does not require excision. Nagi CS, O'Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM. Cancer; 2008 May 15; 112(10):2152-8. PubMed ID: 18348299 [Abstract] [Full Text] [Related]
35. Epidemiological survey of preinvasive breast cancer. Vandenbroucke A, Bourdon C. Eur J Cancer Prev; 1993 Nov 15; 2 Suppl 3():3-10. PubMed ID: 8298449 [Abstract] [Full Text] [Related]
36. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A. J Clin Oncol; 2005 Aug 20; 23(24):5534-41. PubMed ID: 16110014 [Abstract] [Full Text] [Related]
37. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ. Miller ME, Muhsen S, Zabor EC, Flynn J, Olcese C, Giri D, Van Zee KJ, Pilewskie M. Ann Surg Oncol; 2019 Dec 20; 26(13):4317-4325. PubMed ID: 31552614 [Abstract] [Full Text] [Related]
38. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D. Brachytherapy; 2008 Dec 20; 7(1):29-36. PubMed ID: 18201940 [Abstract] [Full Text] [Related]
39. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma. Wallace AS, Xiang D, Hockman L, Arya M, Jeffress J, Wang Z, Dale PS. Eur J Surg Oncol; 2014 Oct 20; 40(10):1245-9. PubMed ID: 24857380 [Abstract] [Full Text] [Related]
40. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A. Cancer; 2001 May 15; 91(10):1862-9. PubMed ID: 11346867 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]